We also found that leukocyte expression levels of the cellular senescence marker p21 were lower in PD versus controls, whilst lower p16 expression at baseline was associated with faster motor and cognitive progression over 36 months; thus, supporting the hypothesis that immunosenescence is reduced in PD. This evidence concerns the gene CDKN2A and Parkinson disease.